All publications, including patents and patent applications, mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication was specifically and individually indicated to be incorporated by reference.
Described herein are devices and methods for use in blood donation and blood management. In particular, described herein are devices and methods for acquiring blood donations.
Blood collection from a donor typically requires piercing the subject's skin with a needle, usually after the area of the subject's skin to be pierced is cleaned (e.g., with alcohol, iodine, or the like). Bacteria present on the skin can enter the blood component collecting bag together with the blood. Indeed, it has been found that some kinds of skin-borne bacteria that may enter the blood collecting bag in this manner may multiply even if blood collecting bag is kept cold. When the collected blood is transfused into a patient, the patient may suffer from infectious disease or blood poisoning.
Although most phlebotomists are trained in techniques to wash or prepare the skin prior to collecting blood, there is a great deal of variability and simple human error associated with collection of blood. For example, the time required to adequately prepare the skin site for needle penetration, including both washing and drying the skin, is not standardized. Even where standard times are applied for each of these steps (e.g., 30 second scrub time), the phlebotomist is generally expected to time herself or himself. Thus, there is a potential for further error and variability which may result in contamination of the collected blood.
The current technique used by most phlebotomists allows the phlebotomist to use a time piece to time a scrubbing procedure, generally their own watch or a clock on the wall. In many instances, a phlebotomist may use one time piece, such as their watch, to initiate a scrubbing procedure, and may then use another time piece, such as a clock on the wall, to monitor the end of the scrubbing procedure. Non-compliance with standardized scrub times can result when the time is not synchronized between these two time pieces. When non-compliance is observed by the FDA, the blood center can be given a 483 non-compliance write-up and be required to respond with a Corrective and Preventative Action, which costs the blood center both time and money.
In view of this and other problems, there is a need for tools, including blood collection apparatuses that may help address these issues. In particular, described herein are blood collection devices that are adapted to provide multiple easy-to-use and accurate timers that may guide the phlebotomist in preparing the subject's skin, and can prevent collection from improperly cleaned skin, as well as methods of using such devices.
In general, described herein are apparatuses and methods of using them to collect blood by first ensuring that the patient's skin is properly cleaned, to prevent contamination of the collected blood. Any of the devices described herein may include an integrated controller with a timer having multiple modes to guide a user (e.g., a phlebotomist) in prepping a subject's skin for a blood draw. The system may include a display (visual) and/or audible output to guide the user, such as a pre-configured countdown for a timer that establishes a predetermined cleaning and drying time (and also potentially additional cleaning/drying cycles). The timer may be hands-free, so that the user only has to trigger the first activation, additional time cycles may be triggered automatically. The system may include a controller that also interfaces with the timer and may record compliance. The system may include a restart function, allowing the user to restart the pre-configured countdown if the cleaning and drying time is missed for any reason. Additionally, the system may include an automated restart function, wherein the pre-configured countdown is restarted if a user reaches the end of the cleaning and drying time without proceeding to the blood collection process for longer than a configured time period.
For example, a blood collection apparatus may include a countdown beep during a preparing to clean (prepare to scrub) period and/or a prepare to dry time period, and/or during a drying period and/or during a cleaning period. In some variations the apparatus or method of operating the apparatus includes a countdown beep only during the preparing time periods (e.g., preparing to clean and preparing to dry time periods). During any of these time periods (first preparing to clean time period, first cleaning time period, second preparing to clean time period, second cleaning time period, preparing to dry time period, drying time periods) a visual countdown may be shown on the display, with or without an audible count down. For example, in some variations a visual countdown may be shown on the display only during the scrub and dry time periods (including displaying without an audible countdown). At the beginning and end of any of these time periods (e.g., the scrub and dry periods), a distinctive audible tone may be made to signal the start or end of that period so the phlebotomist need not be watching the display.
For example, described herein are methods of collecting blood from a patient, the method comprising: initiating, in a blood collection device, a scrub timer having a scrub time period; during the scrub time period, disinfecting tissue of the patient at a needle entry site; and after the scrub time period has elapsed, beginning a blood draw process. The method may include emitting one or more audible beeps from the collection device at the start of the scrub period. The method may include emitting one or more audible beeps from the collection device during the scrub period. The tones emitted may be different. For example, the tones emitted at the start of a preparing to dry period, dry period, preparing to clean period, cleaning period, etc. may be different from each other and from the tones emitted to count down these periods. For example, the tones may be different in frequency, pitch, volume, scale, intensity, etc. Thus, for example, the method may include audibly counting down the scrub time period. For example, the method may include emitting a series of audible beeps counting down the scrub period. In some variations, the method may include: initiating, in the blood collection device immediately after the scrub time period has elapsed, a prepare to dry timer having a prepare to dry time period; and audibly counting down the prepare to dry period. The method may also include initiating, in the blood collection device immediately after the scrub time period has elapsed, a prepare to dry timer having a prepare to dry time period; during the prepare to dry period, performing a secondary wash of the patient at the needle entry site; and audibly counting down the prepare to dry period during the prepare to dry time period. After the disinfecting tissue step, the method (system) may automatically initiate in the blood collection device a dry timer having a dry time period; and drying tissue of the patient at the needle entry site during the dry time period.
For example, described herein are methods of collecting blood from a patient, the method comprising: initiating, in a blood collection device, a scrub timer having a scrub time period; audibly counting down the scrub timer during the scrub time period; automatically initiating, in the blood collection device after the scrub time period has elapsed, a dry timer having a dry time period; audibly counting down the dry timer during the dry time period; and beginning a blood draw process after the dry time period has elapsed. The method may also include initiating, in the blood collection device immediately after the scrub time period has elapsed, a prepare to dry timer having a prepare to dry time period; and audibly counting down the prepare to dry period.
Devices and systems configured to implement these methods are also included. For example, a blood collection device may include: a support configured to hold a blood collection bag; a pinch valve configured to engage a tube leading from the blood collection bag to a patient; a controller configured to control the blood collection device including the pinch valve; and a scrub timer coupled to the controller and configured to indicate to a user a scrub time period prior to beginning a blood draw process.
The GUI 110 allows a user (e.g., a phlebotomist) to configure, calibrate, and setup the blood collection device for use. GUI 110 may display information to the user such as calibration status of the blood collection device 106. In some embodiments, the GUI 110 displays information to the user such as calibration status of the device bag tray 112, weight of the blood donation bag 118, and operation status of the device (e.g., calibration, blood collection underway, blood collection complete, errors during collection, etc.). During initial setup of the device, a user may be asked to zero or calibrate the device, with no weight on the bag tray 112 to ensure accurate measurement of collected blood.
In some embodiments, the device comprises an agitation system suspended on the internal load cell. The agitation system can comprise a motor-driven crank configured to agitate/shake the bag tray 112 and the blood donation bag 118 during blood collection. The agitation system can be designed for minimal weight and optimized for the power required to agitate/shake the bag tray 112 and thus, the blood bag.
When a blood collection bag is placed on the bag tray 112, vertical oscillations of the agitation system can cause blood collected from a donor to flow from one end of the bag to the other, resulting in gentle mixing of the blood and the contained anticoagulant and/or additives. Since the agitation system is mounted on the internal load cell, the load cell can then sense the weight of the bag tray 112, the agitation system, the blood bag, and the accumulated blood.
The blood collection device can further include a pinch valve 114 configured to open and close the blood bag line leading from the patient to the blood donation bag 118. Thus, the blood collection device can be configured to open the pinch valve 114 when the blood collection process begins and close the pinch valve when the blood collection is complete, e.g., when the load cell indicates that the blood donation bag is full.
The blood collection device is configured to automatically measure the weight of accumulated blood during the blood collection process. In some embodiments, the weight of the accumulated blood is measured every time the blood bag and bag tray 112 are in a relatively stable position. In other embodiments, the accumulated blood is measured continuously. By regularly monitoring the weight of collected blood, the blood collection device can calculate blood flow rates from the patient to the blood collection bag. The weight measurements and or flow rates can be used to determine when the blood collection process is complete.
When a blood collection is started, the blood collection device can first implement a series of weight readings of the empty blood bag, the agitation system, and the bag tray assembly. This can be recorded in the device's memory as the tare weight. The desired collection volume can be converted mathematically from weight to volume by using the specific gravity of blood, e.g., of 1.058. (1.00 ml of blood weighs 1.058 grams); this may be configurable on the device between 1.050 to 1.060. This converted weight value plus the tare weight results in the target weight and is compared against on-going weight readings as the collection proceeds. The blood collection device can then open the pinch valve to begin the blood collection process.
The agitation system can be left off until a small increase in weight is seen over the tare weight. As soon as the weight increase is seen by the blood collection device, the agitation system can initiate the shacking/rocking, and various other timing and flow functions can be activated. The blood collection device can continue to read the weight of the blood collection bag. Although these readings are relatively accurate, in some embodiments for greater accuracy, the blood collection system can stop the agitation process when the total weight is slightly less than the target weight. The final readings of collected blood can then be taken with the bag and bag tray in a horizontal position. At this point, it is unnecessary to continue agitating the bag since the anticoagulant is already fully mixed with the blood in the bag. Alternatively, the shaking/rocking could continue throughout the collection provided that accuracy of the weight readings could be assured.
Typically blood bank standards require that blood collections must be completed in a set period of time (20 minutes maximum for current US regulations), smaller volumes of collection can tolerate a slower flow rate. In some embodiments, the blood collection device measures the flow rate and compares it against a computed constant, equal to a minimum flow value for the set period of time described above. As a result, if the required volume is greater, the flow rate must be greater to accomplish the fill in the set period of time (e.g., 20 minutes). If the required volume is less, the flow rate can be slower.
The blood collection device 106 can also include a barcode scanner 116 configured to read a barcode as an input to the device. For example, donation ID's unique to individual donors can be scanned during the blood collection process to keep track of all collection events related to that unique donation ID. In one embodiment, the donation ID can be represented as a barcode 120 located on blood donation bag 118.
The blood collection device 106 can be in communication with control system 108 during all steps of the blood collection process described above (e.g., calibration, blood collection, scrub and dry timing, and completion of the blood draw). The blood collection device and control system can communicate via any technology known in the art, such as wirelessly through a WiFi or Bluetooth connection, or through a wired Ethernet connection. The control system can comprise a computer having all the necessary hardware (e.g., CPU, memory, data storage, etc.) required to execute a data collection and management software.
Scrub Timer
In some embodiments, the blood collection device 106 can include a scrub timer 122. The scrub timer can be configured to aid a phlebotomist in cleaning and preparing a needle entry site prior to blood collection. Some blood collection requirements or guidelines require that a needle entry site of the patient be scrubbed or cleaned for a certain period of time. For example, prepping for a blood collection typically involves disinfecting the tissue around the needle entry site for at least 30 seconds with a 70% or higher alcohol swab, or alternatively, with an iodine solution. The tissue can then be dried before the blood collection process begins. If this disinfecting step is skipped, or if the phlebotomist does not scrub the tissue entry site for the proper amount of time, the blood collected from that patient can be compromised.
Referring still to
Next, at step 204 of flowchart 200, the blood collection device can optionally start a “prepare to scrub” timer. This “prepare to scrub” timer can be displayed or audibly presented to the user to prepare them for the next step. For example, the “prepare to scrub” timer can be a short countdown, e.g., 5 seconds, to indicate to the user of the blood collection device that the scrub step is about to begin. In some embodiments, there is no “prepare to scrub” timer and the blood collection device goes directly from step 202 to step 206, below.
At step 206 of flowchart 200, the blood collection device can start the scrub timer. As described above, the duration of the scrub timer can be pre-set by the user, and can be a visual countdown or timer, or optionally can be audible words, beeps, or sounds. If the scrub timer is a visual countdown or running timer displayed on a GUI of the blood collection device, the user can look at the device to see how much time remains or has passed in the scrub. When the scrub timer begins in step 206, the user or phlebotomist can begin scrubbing the patient's skin surrounding the needle entry site, and can stop the scrubbing process when the scrub timer expires (or reaches the pre-configured scrub time). Scrubbing during the entire duration of the scrub timer ensures that proper scrub protocol has been followed by the phlebotomist.
In some scenarios, a phlebotomist may be required to perform a secondary scrub, or alternatively, may be required to dry the tissue around the needle entry site after the initial scrub. For example, some alcohol based scrubs require that the skin be dried before a needle is inserted into the patient. Alternatively, if an iodine solution is used for the initial scrub, some blood centers require a secondary scrub to further disinfect the patient. In either of these instances, steps 208 and 210 can be optionally implemented with a scrub timer feature of a blood collection device during a blood collection process.
At step 208 of flowchart 200, the blood collection device can optionally start a “prepare to dry” timer. This “prepare to dry” timer can be displayed or audibly presented to the user to prepare them for the next step. For example, the “prepare to dry” timer can be a short countdown, e.g., 5 seconds, to indicate to the user of the blood collection device that the drying step is about to begin. In some embodiments, the “prepare to dry” timer can be replaced with a second “prepare to scrub” timer if a second scrub is required.
At step 210 of flowchart 200, the blood collection device can start the dry timer. As described above, the duration of the dry timer can be pre-set by the user, and can be a visual countdown or timer, or optionally can be audible words, beeps, or sounds. If the dry timer is a visual countdown or running timer displayed on a GUI of the blood collection device, the user can look at the device to see how much time remains or has passed in the drying process. When the dry timer starts in step 210, the user can begin the drying process, and can stop the drying process when the dry timer expires (or reaches the pre-configured dry time). As with step 208, the dry timer can be replaced with an optional second scrub timer if a second scrub is required.
At step 212 of flowchart 200, the scrub and/or dry timer can manually or automatically be restarted. For example, if the phlebotomist fails to comply with the scrub and/or dry timer and realizes the non-compliance, the phlebotomist can interface with the blood collection device to restart the scrub and/or dry timer (e.g., by pushing a button on the device). Alternatively, the blood collection device can automatically restart the scrub and/or dry timer if for example, the phlebotomy process does not begin within a predetermined time period following the completion of the scrub and/or dry time period.
Finally, at step 214 of flowchart 200, the phlebotomy process can begin, and blood can be drawn from the patient. Steps 202-212 above can be implemented in a scrub timer of the blood collection device to ensure that proper scrub protocol is followed, thereby decreasing the chances that the blood collected from the patient is rejected for failing to follow scrub protocol.
When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.
Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.
As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.
Although various illustrative embodiments are described above, any of a number of changes may be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed may often be changed in alternative embodiments, and in other alternative embodiments one or more method steps may be skipped altogether. Optional features of various device and system embodiments may be included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.
The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
This application claims the benefit under 35 U.S.C. 119 of U.S. Provisional Patent Application No. 62/005,673, filed May 30, 2014, titled “SYSTEMS AND METHODS FOR MANAGING BLOOD DONATIONS”. This application is herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4083363 | Philpot, Jr. | Apr 1978 | A |
4377852 | Thompson | Mar 1983 | A |
4451158 | Selwyn | May 1984 | A |
RE33924 | Valeri | May 1992 | E |
5403279 | Inaba et al. | Apr 1995 | A |
5403304 | Ishida | Apr 1995 | A |
5611048 | Jacobs et al. | Mar 1997 | A |
5658240 | Urdahl et al. | Aug 1997 | A |
5666500 | Roberson | Sep 1997 | A |
5845289 | Baumeister et al. | Dec 1998 | A |
5857194 | Kelliher et al. | Jan 1999 | A |
5912669 | Hsia | Jun 1999 | A |
5973665 | Davie et al. | Oct 1999 | A |
6008811 | McMillan | Dec 1999 | A |
6014702 | King et al. | Jan 2000 | A |
6026684 | Calder | Feb 2000 | A |
6049832 | Brim et al. | Apr 2000 | A |
6113554 | Gilcher et al. | Sep 2000 | A |
6131510 | Gasquez | Oct 2000 | A |
6216164 | Zaremba | Apr 2001 | B1 |
6233525 | Langley et al. | May 2001 | B1 |
6252591 | Dockweiler et al. | Jun 2001 | B1 |
6256643 | Cork et al. | Jul 2001 | B1 |
6259447 | Kanetake et al. | Jul 2001 | B1 |
6289382 | Bowman Amuah | Sep 2001 | B1 |
6327624 | Mathewson et al. | Dec 2001 | B1 |
6332163 | Bowman Amuah | Dec 2001 | B1 |
6334144 | Horwitz | Dec 2001 | B1 |
6339832 | Bowman Amuah | Jan 2002 | B1 |
6342905 | Diedrich et al. | Jan 2002 | B1 |
6366658 | Bjornberg et al. | Apr 2002 | B1 |
6381654 | Brawn et al. | Apr 2002 | B1 |
6402702 | Gilcher et al. | Jun 2002 | B1 |
6405924 | Shah | Jun 2002 | B1 |
6406919 | Tyrrell | Jun 2002 | B1 |
6434568 | Bowman Amuah | Aug 2002 | B1 |
6434628 | Bowman Amuah | Aug 2002 | B1 |
6438594 | Bowman Amuah | Aug 2002 | B1 |
6442748 | Bowman Amuah | Aug 2002 | B1 |
6446110 | Lection et al. | Sep 2002 | B1 |
6453356 | Sheard et al. | Sep 2002 | B1 |
6477580 | Bowman Amuah | Nov 2002 | B1 |
6477665 | Bowman Amuah | Nov 2002 | B1 |
6480895 | Gray et al. | Nov 2002 | B1 |
6496850 | Bowman Amuah | Dec 2002 | B1 |
6502213 | Bowman Amuah | Dec 2002 | B1 |
6508778 | Verkaart et al. | Jan 2003 | B1 |
6511439 | Tabata et al. | Jan 2003 | B1 |
6519605 | Gilgen et al. | Feb 2003 | B1 |
6529909 | Bowman Amuah | Mar 2003 | B1 |
6529948 | Bowman Amuah | Mar 2003 | B1 |
6539396 | Bowman Amuah | Mar 2003 | B1 |
6549949 | Bowman Amuah | Apr 2003 | B1 |
6550057 | Bowman Amuah | Apr 2003 | B1 |
6571282 | Bowman Amuah | May 2003 | B1 |
6578068 | Bowman Amuah | Jun 2003 | B1 |
6582386 | Min et al. | Jun 2003 | B2 |
6601192 | Bowman Amuah | Jul 2003 | B1 |
6601234 | Bowman Amuah | Jul 2003 | B1 |
6606660 | Bowman Amuah | Aug 2003 | B1 |
6611806 | Harvey | Aug 2003 | B1 |
6615199 | Bowman Amuah | Sep 2003 | B1 |
6615253 | Bowman Amuah | Sep 2003 | B1 |
6622176 | Jones et al. | Sep 2003 | B2 |
6636242 | Bowman Amuah | Oct 2003 | B2 |
6640238 | Bowman Amuah | Oct 2003 | B1 |
6640244 | Bowman Amuah | Oct 2003 | B1 |
6640249 | Bowman Amuah | Oct 2003 | B1 |
6641552 | Kingsley et al. | Nov 2003 | B1 |
6665868 | Knowles et al. | Dec 2003 | B1 |
6673314 | Burbank et al. | Jan 2004 | B1 |
6714945 | Foote et al. | Mar 2004 | B1 |
6715145 | Bowman Amuah | Mar 2004 | B1 |
6718334 | Han | Apr 2004 | B1 |
6730054 | Pierce et al. | May 2004 | B2 |
6742015 | Bowman Amuah | May 2004 | B1 |
6773413 | Keller et al. | Aug 2004 | B2 |
6808503 | Farrell et al. | Oct 2004 | B2 |
6816880 | Strandberg et al. | Nov 2004 | B1 |
6842906 | Bowman Amuah | Jan 2005 | B1 |
6862573 | Kendall et al. | Mar 2005 | B2 |
6884228 | Brown et al. | Apr 2005 | B2 |
6934848 | King et al. | Aug 2005 | B1 |
6944596 | Gray et al. | Sep 2005 | B1 |
6949079 | Westberg et al. | Sep 2005 | B1 |
6976164 | King et al. | Dec 2005 | B1 |
6980989 | Silverman et al. | Dec 2005 | B2 |
6994790 | Corbin et al. | Feb 2006 | B2 |
6996542 | Landry | Feb 2006 | B1 |
7072769 | Fletcher Haynes et al. | Jul 2006 | B2 |
7076032 | Pirasteh et al. | Jul 2006 | B1 |
7087047 | Kraus et al. | Aug 2006 | B2 |
7169352 | Felt et al. | Jan 2007 | B1 |
7219094 | Schiel et al. | May 2007 | B2 |
7269844 | Elteto et al. | Sep 2007 | B2 |
7289964 | Bowman Amuah | Oct 2007 | B1 |
7334015 | Phillips | Feb 2008 | B1 |
7354415 | Bainbridge et al. | Apr 2008 | B2 |
7373373 | McElhannon | May 2008 | B2 |
7380024 | Peterson et al. | May 2008 | B2 |
7415438 | Berman et al. | Aug 2008 | B1 |
7421427 | DeForeest et al. | Sep 2008 | B2 |
7430478 | Fletcher-Haynes et al. | Sep 2008 | B2 |
7434166 | Acharya et al. | Oct 2008 | B2 |
7454399 | Matichuk | Nov 2008 | B2 |
7475143 | Hartmann et al. | Jan 2009 | B2 |
7479123 | Briggs | Jan 2009 | B2 |
7540021 | Page | May 2009 | B2 |
7558777 | Santos | Jul 2009 | B1 |
7566315 | Hirabuki | Jul 2009 | B2 |
7574376 | Berman et al. | Aug 2009 | B1 |
7597250 | Finn | Oct 2009 | B2 |
7704454 | Langley et al. | Apr 2010 | B1 |
7708710 | Min et al. | May 2010 | B2 |
7739227 | Jordan et al. | Jun 2010 | B2 |
7752178 | Anderson | Jul 2010 | B2 |
7754149 | Sugiyama | Jul 2010 | B2 |
7844472 | Akin et al. | Nov 2010 | B1 |
7844521 | Hoag et al. | Nov 2010 | B1 |
7850634 | Briggs | Dec 2010 | B2 |
7860726 | Connely et al. | Dec 2010 | B2 |
7877402 | Weiss et al. | Jan 2011 | B1 |
7900298 | Char et al. | Mar 2011 | B1 |
7937583 | Thornton et al. | May 2011 | B2 |
7949546 | Klieman et al. | May 2011 | B1 |
7962899 | McCullough et al. | Jun 2011 | B2 |
7992203 | Relyea | Aug 2011 | B2 |
8036987 | Grbac et al. | Oct 2011 | B1 |
8060382 | Lee et al. | Nov 2011 | B1 |
8060423 | Rukonic et al. | Nov 2011 | B1 |
8060500 | Fitch et al. | Nov 2011 | B1 |
8086730 | Ribak et al. | Dec 2011 | B2 |
8108227 | Rogers et al. | Jan 2012 | B1 |
8108271 | Duncan et al. | Jan 2012 | B1 |
8146000 | Boliek et al. | Mar 2012 | B1 |
8155950 | Bickerstaff | Apr 2012 | B1 |
8166473 | Kinsey et al. | Apr 2012 | B2 |
8170958 | Gremett et al. | May 2012 | B1 |
8185426 | Khoubyari | May 2012 | B1 |
8196061 | Bhojan | Jun 2012 | B1 |
8204805 | Eftekhari et al. | Jun 2012 | B2 |
8209229 | Weiss et al. | Jun 2012 | B1 |
8214276 | Preece et al. | Jul 2012 | B1 |
8219504 | Weiss et al. | Jul 2012 | B1 |
8280787 | Gandhi | Oct 2012 | B1 |
8285622 | Rao et al. | Oct 2012 | B1 |
8286199 | Pulaski et al. | Oct 2012 | B1 |
8291047 | Liu et al. | Oct 2012 | B2 |
8296206 | Del Favero et al. | Oct 2012 | B1 |
8306255 | Degnan | Nov 2012 | B1 |
8321309 | Jain et al. | Nov 2012 | B1 |
8326725 | Elwell et al. | Dec 2012 | B2 |
8335728 | Dahodwala et al. | Dec 2012 | B1 |
8346753 | Hayes | Jan 2013 | B2 |
8346929 | Lai | Jan 2013 | B1 |
8352350 | Del Favero et al. | Jan 2013 | B1 |
8364522 | Gevelber | Jan 2013 | B1 |
8375324 | Zubizarreta et al. | Feb 2013 | B1 |
8380590 | Rukonic et al. | Feb 2013 | B1 |
8407113 | Eftekhari et al. | Mar 2013 | B1 |
8452748 | Pugh | May 2013 | B1 |
8463622 | Garms et al. | Jun 2013 | B2 |
8468130 | Bhandari et al. | Jun 2013 | B2 |
8473263 | Tolone et al. | Jun 2013 | B2 |
8473858 | Buchanan et al. | Jun 2013 | B2 |
8484626 | Nagulu et al. | Jul 2013 | B2 |
8495596 | Safavi-Naini | Jul 2013 | B1 |
8521628 | Gowen et al. | Aug 2013 | B1 |
8527291 | Kochendorfer | Sep 2013 | B1 |
8543932 | Fields et al. | Sep 2013 | B2 |
8566313 | Zubizarreta et al. | Oct 2013 | B1 |
8568356 | Lebel et al. | Oct 2013 | B2 |
8571885 | Andros et al. | Oct 2013 | B2 |
8600835 | Lueck | Dec 2013 | B1 |
8640105 | Yaffe | Jan 2014 | B2 |
8649770 | Cope et al. | Feb 2014 | B1 |
8655726 | Favero et al. | Feb 2014 | B1 |
8660945 | Pariante et al. | Feb 2014 | B1 |
8668138 | Schwarz et al. | Mar 2014 | B1 |
8688504 | Reisman | Apr 2014 | B2 |
8689016 | Morten et al. | Apr 2014 | B2 |
8707409 | Shah et al. | Apr 2014 | B2 |
8713005 | Benson | Apr 2014 | B2 |
8744197 | Fertik et al. | Jun 2014 | B2 |
8744923 | McKay et al. | Jun 2014 | B1 |
8751292 | Del Favero et al. | Jun 2014 | B2 |
8752170 | Newstadt et al. | Jun 2014 | B1 |
8768833 | Freishtat et al. | Jul 2014 | B2 |
8775070 | Bhatia | Jul 2014 | B1 |
8793777 | Colson | Jul 2014 | B2 |
8798596 | Shuster et al. | Aug 2014 | B2 |
8826145 | Kirkpatrick et al. | Sep 2014 | B1 |
20020013523 | Csore et al. | Jan 2002 | A1 |
20020087356 | Andros et al. | Jul 2002 | A1 |
20020116219 | Ibok et al. | Aug 2002 | A1 |
20030004751 | Ng et al. | Jan 2003 | A1 |
20030032868 | Graskov et al. | Feb 2003 | A1 |
20030037023 | Lyakovetsky et al. | Feb 2003 | A1 |
20030040835 | Ng et al. | Feb 2003 | A1 |
20030069480 | Ng et al. | Apr 2003 | A1 |
20030120593 | Bansal et al. | Jun 2003 | A1 |
20030154108 | Fletcher Haynes et al. | Aug 2003 | A1 |
20030002002 | Wells et al. | Oct 2003 | A1 |
20030229846 | Sethi et al. | Dec 2003 | A1 |
20040046787 | Henry et al. | Mar 2004 | A1 |
20040103040 | Ronaghi et al. | May 2004 | A1 |
20040117376 | Lavin et al. | Jun 2004 | A1 |
20040153432 | O'Halloran et al. | Aug 2004 | A1 |
20040171983 | Sparks et al. | Sep 2004 | A1 |
20040193613 | Armand | Sep 2004 | A1 |
20040214148 | Salvino et al. | Oct 2004 | A1 |
20040230216 | LeVaughn et al. | Nov 2004 | A1 |
20040267562 | Fuhrer et al. | Dec 2004 | A1 |
20050038675 | Siekman et al. | Feb 2005 | A1 |
20050071193 | Kalies | Mar 2005 | A1 |
20050096973 | Heyse et al. | May 2005 | A1 |
20050137908 | Fusari et al. | Jun 2005 | A1 |
20050182726 | Honeycutt et al. | Aug 2005 | A1 |
20050204900 | Burton | Sep 2005 | A1 |
20050234964 | Batra et al. | Oct 2005 | A1 |
20050240437 | Cunningham | Oct 2005 | A1 |
20050243655 | McCutcheon et al. | Nov 2005 | A1 |
20050278261 | Omanson et al. | Dec 2005 | A1 |
20060026067 | Nicholas et al. | Feb 2006 | A1 |
20060026519 | Vaindiner et al. | Feb 2006 | A1 |
20060075224 | Tao | Apr 2006 | A1 |
20060085478 | Landau et al. | Apr 2006 | A1 |
20060111943 | Wu | May 2006 | A1 |
20060190566 | Roach | Aug 2006 | A1 |
20060247971 | Dresden et al. | Nov 2006 | A1 |
20070055483 | Lee et al. | Mar 2007 | A1 |
20070106647 | Schwalb | May 2007 | A1 |
20070112574 | Greene | May 2007 | A1 |
20070130111 | Stoudt et al. | Jun 2007 | A1 |
20070143660 | Huey et al. | Jun 2007 | A1 |
20070198744 | Wensley et al. | Aug 2007 | A1 |
20070219826 | Brodsky et al. | Sep 2007 | A1 |
20070220494 | Spooner | Sep 2007 | A1 |
20070250390 | Lee et al. | Oct 2007 | A1 |
20070276678 | Nichols | Nov 2007 | A1 |
20070282280 | Tennican | Dec 2007 | A1 |
20080064986 | Kraemer et al. | Mar 2008 | A1 |
20080097952 | Eswaran | Apr 2008 | A1 |
20080132311 | Walker | Jun 2008 | A1 |
20080133551 | Wensley et al. | Jun 2008 | A1 |
20080133736 | Wensley et al. | Jun 2008 | A1 |
20080148160 | Holmes et al. | Jun 2008 | A1 |
20080208750 | Chen | Aug 2008 | A1 |
20090037264 | Del Favero et al. | Feb 2009 | A1 |
20090037266 | Weiss et al. | Feb 2009 | A1 |
20090048870 | Godshall et al. | Feb 2009 | A1 |
20090076885 | Fein et al. | Mar 2009 | A1 |
20090187462 | Gevelber et al. | Jul 2009 | A1 |
20090191174 | Boudreau et al. | Jul 2009 | A1 |
20090204964 | Foley et al. | Aug 2009 | A1 |
20090288037 | Lawton et al. | Nov 2009 | A1 |
20100049542 | Benjamin et al. | Feb 2010 | A1 |
20100049576 | Wilson et al. | Feb 2010 | A1 |
20100063838 | Schumacher et al. | Mar 2010 | A1 |
20100083358 | Govindarajan et al. | Apr 2010 | A1 |
20100100424 | Buchanan et al. | Apr 2010 | A1 |
20100138241 | Ruark et al. | Jun 2010 | A1 |
20100142447 | Schlicht et al. | Jun 2010 | A1 |
20100168615 | Amano et al. | Jul 2010 | A1 |
20100205112 | Reynolds et al. | Aug 2010 | A1 |
20100215280 | Abdo et al. | Aug 2010 | A1 |
20100256974 | Xu et al. | Oct 2010 | A1 |
20100269049 | Fearon | Oct 2010 | A1 |
20100306080 | Trandal et al. | Dec 2010 | A1 |
20110010214 | Carruth | Jan 2011 | A1 |
20110022425 | Block et al. | Jan 2011 | A1 |
20110041153 | Simon et al. | Feb 2011 | A1 |
20110047230 | McGee | Feb 2011 | A1 |
20110106759 | Brown | May 2011 | A1 |
20110130114 | Boudville | Jun 2011 | A1 |
20110191254 | Womack | Aug 2011 | A1 |
20120010553 | Alqvist et al. | Jan 2012 | A1 |
20120016721 | Weinman | Jan 2012 | A1 |
20120022892 | Feldman et al. | Jan 2012 | A1 |
20120036565 | Gamez et al. | Feb 2012 | A1 |
20120054625 | Pugh et al. | Mar 2012 | A1 |
20120072232 | Frankham et al. | Mar 2012 | A1 |
20120096021 | Wiser et al. | Apr 2012 | A1 |
20120130962 | Wiser et al. | May 2012 | A1 |
20120136678 | Steinberg | May 2012 | A1 |
20120173397 | Elwell et al. | Jul 2012 | A1 |
20120191703 | Huff | Jul 2012 | A1 |
20120191716 | Omoigui | Jul 2012 | A1 |
20120215560 | Wartenfeld et al. | Aug 2012 | A1 |
20120218127 | Kroen | Aug 2012 | A1 |
20120253801 | Santos-Lang et al. | Oct 2012 | A1 |
20120265099 | Goodnow et al. | Oct 2012 | A1 |
20120329529 | van der Raadt | Dec 2012 | A1 |
20130030889 | Davich et al. | Jan 2013 | A1 |
20130061323 | Liske | Mar 2013 | A1 |
20130096501 | Arene et al. | Apr 2013 | A1 |
20130138501 | Litzow et al. | May 2013 | A1 |
20130202482 | Froimson | Aug 2013 | A1 |
20130204778 | Connors et al. | Aug 2013 | A1 |
20130290408 | Stephure et al. | Oct 2013 | A1 |
20130291024 | Lefevre et al. | Oct 2013 | A1 |
20130297349 | Epstein et al. | Nov 2013 | A1 |
20130304496 | Rangadass | Nov 2013 | A1 |
20130339858 | Corfield | Dec 2013 | A1 |
20130346144 | Ferren et al. | Dec 2013 | A1 |
20130346527 | Shah et al. | Dec 2013 | A1 |
20140004949 | Miura et al. | Jan 2014 | A1 |
20140004956 | Miura et al. | Jan 2014 | A1 |
20140033230 | Hanna et al. | Jan 2014 | A1 |
20140046678 | Lacy et al. | Feb 2014 | A1 |
20140052469 | Andros et al. | Feb 2014 | A1 |
20140052680 | Nitz et al. | Feb 2014 | A1 |
20140052681 | Nitz et al. | Feb 2014 | A1 |
20140077932 | Rooyakkers | Mar 2014 | A1 |
20140088998 | Boyer et al. | Mar 2014 | A1 |
20140095363 | Caldwell | Apr 2014 | A1 |
20140096226 | Barkan | Apr 2014 | A1 |
20140108397 | Zubizarreta et al. | Apr 2014 | A1 |
20140115679 | Barton et al. | Apr 2014 | A1 |
20140122135 | Bain | May 2014 | A1 |
20140136280 | Farahat et al. | May 2014 | A1 |
20140136541 | Farahat et al. | May 2014 | A1 |
20140143270 | Amulu et al. | May 2014 | A1 |
20140149842 | Murthy et al. | May 2014 | A1 |
20140156345 | Eskey et al. | Jun 2014 | A1 |
20140164484 | Vonog et al. | Jun 2014 | A1 |
20140172625 | Reisman | Jun 2014 | A1 |
20140172751 | Greenwood | Jun 2014 | A1 |
20140180802 | Boal | Jun 2014 | A1 |
20140188649 | Messinger et al. | Jul 2014 | A1 |
20140189048 | Messinger et al. | Jul 2014 | A1 |
20140189851 | Domke et al. | Jul 2014 | A1 |
20140189876 | Messinger et al. | Jul 2014 | A1 |
20140207521 | Onder et al. | Jul 2014 | A1 |
20140207601 | Soorianarayanan et al. | Jul 2014 | A1 |
20140207862 | Domke et al. | Jul 2014 | A1 |
20140207874 | Soorianarayanan et al. | Jul 2014 | A1 |
20140207875 | Messinger et al. | Jul 2014 | A1 |
20140208159 | Soorianarayanan et al. | Jul 2014 | A1 |
20140208163 | Domke et al. | Jul 2014 | A1 |
20140244453 | Rephlo | Aug 2014 | A1 |
20150073832 | Goodnow et al. | Mar 2015 | A1 |
Number | Date | Country |
---|---|---|
1348740 | May 2002 | CN |
1503954 | Jun 2004 | CN |
1674030 | Sep 2005 | CN |
101982006 | Feb 2011 | CN |
1470781 | Oct 2004 | EP |
2465421 | Jun 2012 | EP |
2435113 | Aug 2007 | GB |
08-240589 | Sep 1996 | JP |
2003-0063426 | Jul 2003 | KR |
2005-0072937 | Jul 2005 | KR |
2005-0075502 | Jul 2005 | KR |
2008-0017470 | Feb 2008 | KR |
WO2002069793 | Sep 2002 | WO |
WO2015184462 | Dec 2015 | WO |
Entry |
---|
WHO Guidelines for drawing blood, May 19, 2010. http://www.who.int/injection_safety/phleb_final_screen_ready.pdf. |
World Health Organization; WHO guidelines on drawing blood; © 2010; 5 pages; retrieved from the internet (http://www.ncbi.nim.nih.gov/books/NBK138671) on Aug. 14, 2015. |
Armstrong; Blood Collection; ISBT Science Series; 3(2); pp. 123-136; Jun. 2008. |
McDonald et al.; A novel rapid and effective donor arm disinfection method; Transfusion; 50(1); pp. 53-58; Jan. 2010. |
Patel et al.; Impact of donor arm cleaning with different aseptic solutions for prevention of contamination in blood bags; Indian Journal of Hematol Blood Transfus; 29(1); pp. 17-20; Mar. 2013. |
Kappestin; Nasokomiale Infektionen Pravention; Labordiagnostik; Antimkrobielle Therapie Thieme; 4th Edition; Jul. 15, 2009 (English Abstract). |
Trautmann et al.; Anforderungen an die Hygiene bei Punktionen und Injektionen. Bundesgesundheitsblatt; Gesundheitsforschung; Gesundheitsschutz; vol. 54; pp. 1135-1144; Sep. 2011 (English Abstract). |
Number | Date | Country | |
---|---|---|---|
20150343123 A1 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
62005673 | May 2014 | US |